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In 1950, the first large-scale epidemiological studies demonstrated that lung cancer is causatively associated with cigarette smoking, a finding
subsequently confirmed by the Royal College of Physicians in London, the U.S. Surgeon General, and the World Health Organization. Although
cigarette consumption has gradually decreased in the United States from a high of about 3800 cigarettes per adult per year in 1965 to about 2800
cigarettes in 1993, death from lung cancer has reached a high among males at the rate of 74.9/100,0001year and among females at the rate of 28.5.
However, in the younger cohorts, the lung cancer death rate is decreasing in both men and women. In this overview we discuss the steeper
increase during recent decades of lung adenocarcinoma incidence compared with squamous cell carcinoma of the lung. In 1950, the ratio of these
two major types of lung cancer in males was about 1:18; today it is about 1:1.2-1.4. This overview discusses two concepts that are regarded as
contributors to this change in the histological types of lung cancer. One factor is the decrease in average nicotine and tar delivery of cigarettes from
about 2.7 and 38 mg in 1955 to 1.0 and 13.5 mg in 1993, respectively. Other major factors for the reduced emission of smoke relate to changes in
the composition of the cigarette tobacco blend and general acceptance of cigarettes with filter tips; the latter constitute 97% of all cigarettes
currently sold. However, smokers of low-yield cigarettes compensate for the low delivery of nicotine by inhaling the smoke more deeply and by
smoking more intensely; such smokers may be taking up to 5 puffs/min with puff volumes up to 55 ml. Under these conditions, the peripheral lung
is exposed to increased amounts of smoke carcinogens that are suspected to lead to lung adenocarcinoma. Among the important changes in the
composition of the tobacco blend of the U.S. cigarette is a significant increase in nitrate content (0.5% to 1.2-1.5%), which raises the yields of
nitrogen oxides and N-nitrosamines in the smoke. Furthermore, the more intense smoking by the consumers of low-yield cigarettes increases
N-nitrosamines in the smoke 2- to 3-fold. Among the N-nitrosamines is 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), a powerful lung
carcinogen in animals that is exclusively formed from nicotine. This organ-specific tobaco-specific nitrosamine (TSNA) induces adenocarcinoma of
the lung. All of these factors, the more intense smoking, the deeper inhalation of the smoke, and the increased yields of N-nitrosamines in the
smoke of low-yield cigarettes, are considered major contributors to the drastic increase in lung adenocarcinoma among cigarette smokers in recent
years. This overview also discusses the differences in the major lung cancer types in female compared with male smokers as well as the likely
underlying factors for increased lung cancer risk among African Americans compared with that among white Americans. Although the only sure way
to prevent smoking-related diseases is giving up the tobacco habit, there must be a measure of protection for those who cannot accomplish this.
Therefore, setting upper permissible limits of tar levels for the smoke of U.S. cigarettes, similar to strategies already taken in Western Europe,
should be considered. - Environ Health Perspect 103(Suppl 8):143-148 (1995)
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Introduction
The age-adjusted death rate oflung cancer
in the United States has more than doubled
during the past two decades (1). Although
this statistic is well known to public health
officials, it masks an important underlying
trend in the changing histopathology of
lung cancer. Using data from the national
Surveillance, Epidemiology and End
Results (SEER) Registries, Devesa et al. (2)
showed that for a segment accounting for
7% of the U.S. population, the rates of
certain histologic types of cancer increased
much more rapidly than those of other
lung cancer cell types and that these rate
increases differed between men and
women. From 1969 to 1971 to 1984 to
1986, the incidence oflung adenocarci-
noma in the United States increased by
111% in white men and by 151% in black
men. In contrast, the rates for squamous
cell carcinoma increased by only 25 and
50%, respectively. However, among
women, the rates for both adenocarcinoma
and squamous cell cancer increased by
similar percentages. Adenocarcinoma rates
increased by 220% among white women
and 221% among black women, and the
This paperwas presented at the President's Cancer Panel Conference on Avoidable Causes of Cancer held 7-8
April 1994 in Bethesda, Maryland. Manuscript received 9 March 1995; manuscript accepted 24 March 1995.
Supported by U.S. Public Health grant CA-32617 from the National Cancer Institute. The authors appreciate
the editorial assistance of Ilse Hoffmann and JenniferJohnting.
Address correspondence to Joshua E. Muscat; American Health Foundation, Division of Epidemiology, 320
East 43rd Street New York, NY 10017. Telephone: (212) 551-2530. Fax: (212) 687-2339. E-mail:
jqm9937@is2.nyu.edu
Abbreviations used: BAC, bronchioalveolar carcinoma; BMI, body mass index; Cl, confidence interval; ERT,
estrogen replacement therapy; NNK, 4-(methylnitrosamino-143-pyridyl-1butanone; PAH, polynuclear aromatic
hydrocarbons; RR, relative risk; SEER, Surveillance, Epidemiology and End Results; TSNA, tobacco-specific
nitrosamine; OR, odds ratio; Cl, confidence interval.
incidence of squamous cell carcinoma
increased by 156 and 209%, respectively.
These changes have also been observed
in hospital-based studies. In 1950, the first
large-scale case-control study ofcigarette
smoking and lung cancer in the United
States found that adenocarcinoma com-
prised approximately 5% oflung cancers
among men (3). In more recent case-
control studies, we reported that 40% ofall
lung cancer cases had a diagnosis ofadeno-
carcinoma (4). This is well in linewith sev-
eral reports about changes in the ratio of
squamous cell carcinoma to adenocarcinoma
in male cigarette smokers (5-8).
Although lung cancer is the most com-
mon type ofcancer in the United States for
both men andwomen, the reasons for these
temporal patterns in lung cancer histology
remain unknown. Insight into these tem-
poral trends can be gained by examining
changes in the composition of cigarette
smoke due to product modification as well
as changes in smoking habits. While lung
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cancer incidence rates have been increasing
rapidly, the chemical composition ofciga-
rettes consumed in the United States has
changed dramatically. The sales-weighted
average tar and nicotine yields ofall ciga-
rette types, which are based on standardized
machine smoking, have declined approxi-
mately 60% over the past several decades
(9). Changes in the composition and
makeup ofU.S. cigarettes have resulted in
low-tar and low-nicotine cigarettes. Epide-
miological studies have shown that the
long-term smoker who smokes filter-tipped
cigarettes exclusively has a 30 to 50%
reduction ofrisk for lung cancer (10).
The tar yield ofa cigarette reflects many
parameters, including the type oftobacco,
the porosity of the cigarette paper, and the
presence ofa filter with or without perfora-
tions. Tar is that component ofmainstream
tobacco smoke that is retained on a glass
fiber filter, minus nicotine and minus
water (11). Tar contains a number ofcom-
pounds that are lung carcinogens (12,13).
When machine smoked under standard
laboratory conditions, U.S. nonfilter ciga-
rettes have tar yields between 16 and 27
mg/cigarette; filter cigarettes have tar yields
below 20 mg/cigarette (14).
Although lower tar yields would appear
to be less harmful to smokers because of
the reduced concentration of mainstream
smoke carcinogens, the altered chemical
composition ofthe smoke oflow-yield cig-
arettes may actually have a potentiating
effect in terms of the risk of adenocarci-
noma. Two ideas have been suggested to
explain the more pronounced increase in
adenocarcinoma relative to that of squa-
mous cell cancer. One concept suggests that
adenocarcinoma ofthe lung occurs because
of the organ-specific, carcinogenic N-
nitrosamines formed by nitrosation of
nicotine and other minor alkaloids during
processing of tobacco and during smoking
(15,16). During the past four decades, the
sales-weighted average tar and nicotine
yields of U.S. cigarettes have decreased
from about 38 and 2.7 mg to 13.5 and 1.0
mg, respectively (9). These yields are based
on standardized machine smoking condi-
tions of 1 puff/min, a puffvolume of 35
ml, and a puff duration of 2 sec (11).
However, to satisfy their nicotine depen-
dency, many smokers of low-yield filter
cigarettes smoke more intensely, taking up
to 5 puffs/min, with a puffvolume of up
to 55 ml (17-20). When one uses a smok-
ing machine but employs these "human
smoking parameters," the smoke yields
increase 2- to 3-fold for tar, nicotine, carbon
monoxide, and the carcinogenic tobacco-
specific nitrosamine (TSNA) (21-23). In
addition, the smoker oflow-yield cigarettes
has the tendency to inhale more deeply
(24). Consequently, the peripheral lung of
the smoker of low-yield filter cigarettes is
exposed to relatively higher doses ofsmoke,
including polynuclear aromatic hydrocar-
bons (PAHs) as well as carcinogenic TSNA
such as 4-(methylnitrosamino)-1-(3-
pyridyl)-1-butanone (NNK); this is ofcon-
cern because NNK is a systemic carcinogen
that induces lung adenocarcinomas in lab-
oratory animals independent ofthe site of
application (25). In further support ofthe
concept of systemic lung carcinogenesis as
an important contributor to changes in
lung cancer histology, the tobacco blend of
U.S. cigarettes has increased in nitrate con-
tent from about 0.5 to 1.3-1.5%, causing
concomitant higher yields of NNK in the
smoke (16). The systemic carcinogen
hypothesis holds that more intensive smok-
ing of filter cigarettes and the increased
smoke yields ofthe organ-specific carcino-
genic N-nitrosamines, especially that of
NNK, are major contributors to the higher
incidence of lung adenocarcinoma in
smokers, and especially in male smokers. It
is also important to note that the percent-
age of all cigarettes smoked in the United
States that were filter-tipped was 19% in
1955, 51% in 1960, 80% in 1970, 92% in
1980, and more than 97% in 1992 (26).
As an alternative or additional explana-
tion, the "airborne carcinogen hypothesis"
suggests that the significant reduction in
cigarette tar yield that has occurred over
the past four decades has caused smokers to
draw greater puff volumes (18). With
increasing puffvolume, smoke particles are
inhaled into the lung with greater velocity.
This forced inhalation ofthe smoke aerosol
opens the alveoli widely and facilitates the
rapid saturation with nicotine (27). The
secondary and tertiary bronchi ofthe lung
and the alveolar region also lack the
defenses present in the major bronchi (i.e.,
ciliated epithelium and mucus-secreting
cells). Therefore, the peripheral bronchi are
less resistant to the toxic and carcinogenic
constituents ofcigarette smoke. This could
be one reason that the rate ofadenocarci-
noma among women did not increase as
steeply as that among men. Clearly, most
women who smoke have not been exposed
to the same levels and types ofhabituating
agents, toxins, and carcinogens that were
emitted by the high-tar, high-nicotine ciga-
rettes of former decades but instead have
been exposed to the quantitatively different
constituents of the smoke offilter-tipped
cigarettes. This concept is supported by
the observation that 35.5% of male lung
cancer patients who were interviewed dur-
ing 1977 to 1978 smoked nonfilter ciga-
rettes exclusively, while at that time only
13.3% of the female cases reported use of
nonfilter cigarettes. In 1993, these figures
were 19.4% for men and only 7.2% for
women, respectively.
The idea that deeper inhalation causes
primarily adenocarcinomas in the distant
parts of the lung is supported by data
showing that most lung neoplasms among
smokers ofpipes and cigars are squamous
cell carcinomas arising from the major
bronchi (28). Cigars and pipes generate
alkaline smoke with significant amounts of
unprotonated nicotine that are rapidly
absorbed through the oral mucosa, thus
quickly satisfying any craving for nicotine.
Therefore, in contrast to smokers oflow-
yield cigarettes, cigar and pipe smokers
either do not inhale the smoke very deeply,
or not at all (29).
Historically, most long-term smokers in
the United States have smoked nonfilter
cigarettes during their lifetimes but have
switched to filter cigarettes in more recent
years. Relatively few smokers have smoked
filter cigarettes exclusively. And, until
recently, very few people in the United
States have smoked low-tar filter cigarettes
only (<14 mg tar). The effects ofthese low-
tar cigarettes in relation to lung cancer are
unknown. Some studies have shown that
smoking of filter cigarettes that yield
medium levels of tar is not as strongly
related to lung cancer as the smoking of
higher yield nonfilter cigarettes(10,30-32).
Yet it is imperative to continue epidemio-
logic and laboratory studies to delineate the
effects of the low-yield cigarette with
respect to incidence and type oflung can-
cer. If it were proven that smoking ciga-
rettes with low tar yield is less strongly
associated with lung cancer than smoking
cigarettes with higher tar yield, such proof
would constitute a scientific basis for legis-
lation that calls for an upper permissible
tar level for all cigarettes produced. One
step in this direction has already been
taken in the European Common Market
Community in 1993 (33).
However, it is possible that smoking
the low-yield cigarette actually increases
the risk of adenocarcinoma of the lung
compared with smoking cigarettes of
medium yield. As previously discussed, the
smoke of low-yield cigarettes often is
inhaled more deeply into the peripheral
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lung than smoke of high-yield cigarettes.
The peripheral bronchioles have limited
cilia and other defense mechanisms. Thus,
any expected reduction due to the low tar
emission from such cigarettes may be offset
by deeper inhalation and the consequences
thereof. Indirect epidemiologic evidence
supports this hypothesis. Bronchioalveolar
carcinoma (BAC) has been a rare tumor
suspected to be unrelated to cigarette smok-
ing. However, a recent study documented a
clear dose-response relationship between
BAC and years ofcigarette smoking (34).
Some data from a long-standing case-
control study conducted from 1977 to
1994 support these ideas (4). Table 1
reveals that although the risk ofsquamous
cell carcinoma is reduced among the rela-
tively few smokers who only smoked filter
cigarettes during their lifetimes when com-
pared with the risk of other smokers,
smoking low-tar cigarettes is not associated
with a reduced risk ofadenocarcinoma.
Future epidemiologic studies will enable
us to estimate the effects oflifetime smok-
ing oflow-tar cigarettes on lung cancer risk.
This is possible, because the market share of
filter cigarettes ofall cigarettes sold has been
steadily increasing from 0.56% since World
War II to 97% in 1992 (26) and persons
born in the United States after 1944 consti-
tute the first cohort that have smoked pre-
dominantly filter cigarettes (35). These
smokers are now reaching the age when
lung cancer occurs relatively often.
Gender Differences in
Lung Cancer Risk
Since 1950, adenocarcinoma of the lung
has always been relatively more common in
women than in men(13,36-38). Further-
more, the distribution ofneoplasms ofother
cell types such as squamous cell carcinoma
and small cell carcinoma is different among
Table 2. Distribution of lung cancer histology, SEER
Program,a 1983 to 1987.
Cell Type Males, % Females, %
Squamous cell 31.2 19.0
Small cell 16.6 20.2
Large cell 9.3 8.9
Adenocarcinoma 22.7 29.7
Bronchioalveolar 2.5 4.6
Carcinoma
Other 16.7 17.6
'SEER Program, 1983-1987 based on 39,653 male lung
cancers and 20,867 female lung cancers.
women. Table 2 compares lung cancer
histology in the SEER population registries
(39). It is evident that squamous cell carci-
noma is relatively more common in men,
whereas adenocarcinoma and bron-
chioalveolar carcinoma are relatively more
common in women.
Even among nonsmokers, there are gen-
der differences in lung cancer epidemiol-
ogy. An evaluation of the worldwide
epidemiological patterns of lung cancer
among 1325 nonsmoking women showed
that 50 to 80% had adenocarcinoma (40).
Nonsmoking lung cancer patients under 50
years ofage are relatively more likely to be
men than women (41). However, the per-
centage of all nonsmoking lung cancer
patients in our database is much higher for
women than for men (10 vs 3%, respec-
tively). These findings imply that there
may be a differential effect ofsmoking on
lung cancer for men and women or that
some endocrine factor may modify this
association. Some recent evidence supports
this concept (35).
For example, men and women may dif-
fer in their susceptibility to the insults of
tobacco smoke. This could reflect a differ-
ence related to the manner ofsmoking or
an independent effect due to hormonal or
Table 1. Age-adjusted odds ratios for squamous cell carcinoma and adenocarcinoma among current cigarette
smokers, 1977-1994.
Males Females
Type of cancer % OR 95% Cl % OR 95% Cl
Squamous cell carcinoma (n= 699) (n=272)
Lifetime filtera 8.2 1.00 17.3 22.0 1.00
Switchedb21+years ago 18.5 1.77 1.06-2.97 19.5 2.32 1.38-3.90
Switchedb 10-20 years ago 31.7 1.85 1.19-2.89 29.3 1.46 0.91-2.35
Switchedb 1-9 years ago 20.0 2.10 1.27-3.48 17.5 2.15 1.16-3.98
Lifetime nonfilter 21.7 1.91 1.19-3.06 11.8 3.02 1.60-5.72
Adenocarcinoma (n=715) (n=613)
Lifetime filtera 12.0 1.00 27.6 1.00
Switchedb21+years ago 16.0 1.09 0.69-1.73 18.1 1.79 1.18-2.71
Switchedb 10-20 years ago 34.6 1.36 0.93-2.00 32.2 1.36 0.94-1.94
Switchedb 1-9 years ago 18.5 1.14 0.73-1.79 16.5 1.60 0.98-2.60
Lifetime nonfilter 18.9 1.24 0.81-1.90 5.6 1.27 0.70-2.32
'Referent group. bSwitched means switched from nonfilter to filter.
other factors. In recent studies, the relative
risks for lung cancer in women exceeded
those for men for given levels ofsmoking
intensity. Risch et al. (42) reported that
the odds ratio for lung cancer among male
smokers increased from 5.2 for 1 to 30
pack-years to 22.6 for >60 pack years. In
female smokers, the corresponding odds
ratios were 7.3 and 81.9, respectively. Our
own findings suggest that gender differ-
ences are greater for squamous cell cancer
than for adenocarcinoma (43). The likeli-
hood of gender differences in lung cancer
risk is supported by the greater proportion
ofadenocarcinoma in women, the finding
ofestrogen steroid receptors in lung tumor
tissues (44-48), and epidemiologic studies
relating hormonal factors to the devel-
opment of lung cancer (49,50). In addi-
tion, studies have shown that sex hormones
increase the incidence of pulmonary neo-
plasms in laboratory animals (51).
A report by Adami et al. (50) shows a
30% increased rate of lung cancer in
Swedish women who took estrogen replace-
ment therapy. Our own recent observations
suggest that this increased risk is associated
with adenocarcinoma of the lung only.
Women who took estrogen replacement
therapy (ERT) had a significantly elevated
risk (relative risk [RR] 1.7; 95% confi-
dence interval [CI], 1.0-2.8) for adenocar-
cinoma (52). In contrast, no association
was found between ERT and the risk for
squamous cell carcinoma (53). Since mil-
lions ofAmerican women take estrogens to
alleviate postmenopausal symptoms and
prevent osteroporosis, the widespread use
ofthe drugs must be assessed. In addition,
low body weight increases the risk of ade-
nocarcinoma (54,55) and may modify the
risk associated with ERT. Other hormonal
factors may also play a role in the develop-
ment oflung cancer. Studies by Gao et al.
(49) found that Chinese women with short
menstrual cycles had a 3-fold increased risk
oflung cancer. Taioli et al. (52) failed to
confirm this finding, although cycle length
is subject to recall bias (56).
Along related lines, the association
between body mass index (BMI) and the
risk of squamous cell carcinoma and ade-
nocarcinoma has been examined in several
studies. We found that low body mass 5
years prior to diagnosis was significantly
related to the risk oflung cancer in women
(55). Because BMI is also highly related to
levels of smoking, the risk of BMI was
determined separately for different levels of
smoking. Our results were consistent for all
levels of smoking. When examining this
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relationship by histologic tumor type, low
body mass was more strongly related to the
risk of adenocarcinoma than to that for
squamous cell carcinoma (55).
Racial Differences in
Lung Cancer Risk
The lung cancer mortality rate for black
men is 33% higher than that for white
men (39), yet black men smoke fewer
cigarettes per day than white men (57).
However, 40.6% of the population of
black men smoke cigarettes, while only
32.1% of the white male population
smoke cigarettes (58,59). Lung cancer
mortality rates are similar for black and
white women. Ecologic studies of census-
tract data and cancer rates suggest that the
racial differences in cancer rates may
largely be due to socioeconomic status
(60). However, other studies have shown
that poor people smoke less (61). The
higher lung cancer rates among black men
may also be at least partially related to dif-
ferences in diet and occupational expo-
sures. Specific dietary differences are
thought to include a higher intake of fat
from fried meats and lower consumption
ofvegetables among blacks (62).
There are few data on the relative
effects of cigarette smoke in blacks com-
pared with whites even though one study
based on small numbers suggests that
blacks have a greater risk oflung cancer
than whites for a given level of smoking
(43). Host factors may also explain
racial/ethnic differences in lung cancer
incidence. Ethnic differences in the
metabolism ofdrugs and other xenobiotics
have been known for some time (63).
Differences in nicotine metabolism are
reflected by the higher serum levels ofcoti-
nine in blacksmokers than in white smokers
(64). A recent study using urinary bio-
markers of the tobacco-specific lung car-
cinogen NNK showed white smokers to
have a higher ratio of the detoxified
metabolite of NNK relative to the acti-
vated metabolite than black smokers (65).
It is unknown whether the observed racial
differences in metabolism imply a genetic
mechanism. There is no clear evidence of
genetic differences in P450 isozymes (66).
Conclusion
Further research in lung cancer epidemiol-
ogy should focus on determining the
causes of the steeper increase and current
prevalence of adenocarcinoma relative to
squamous cell carcinoma, evaluating gen-
der differences in the risk oflung cancer,
and conducting biochemical-epidemiologi-
cal studies to verify whether racial/ethnic
differences in metabolism of tobacco car-
cinogens are due to a genetic predisposi-
tion or other modifiers. In addition, it is
necessary to monitor the chemical compo-
sition and biological activities ofcigarette
smoke. Since cigarette smoking is the
major cause ofhuman cancer, any changes
in the makeup ofthe tobacco product and
inhalation patterns have a direct impact on
cancer mortality in this country. It is dis-
concerting that only a limited number of
research scientists in the United States are
actively pursuing the epidemiologic and
experimental leads described in this paper.
In theory, reducing the incidence of lung
cancer in the United States can be accom-
plished simply by lowering the prevalence
of cigarette smoking. The national goals
for the year 2000 include a 15% adult
smoking rate. However, after three
decades ofdeclining smoking rates, smok-
ing levels in adults have remained constant
at about 25 to 27% since 1990 (37,67).
Reducing this rate further appears to be an
optimistic goal at this point. However,
recent epidemiologic findings have sug-
gested that the morbidity and mortality
from lung cancer can be reduced by target-
ing certain segments of the population
that may be at higher risk for lung cancer
than other segments (38). Clearly, if the
goal of significantly reduceing the inci-
dence of cancer is to be met by the year
2000, what is done or left undone with
respect to determining lung cancer etiol-
ogy and prevention will determine our
success or failure. Ifcertain segments ofthe
population are at higher risk oflung can-
cer than other groups, cancer prevention
programs need to be especially targeted
toward these groups.
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